Its seriousness varies from person to person. Serous cancer. About 10% of people with endometrial cancer have this rare and fast-growing type of endometrial cancer. It tends to come back even ...

By contrast, type II ECs develop in older patients, are not hormone dependent and are responsible for most recurrences and deaths from EC. Uterine serous cancer constitutes up to 10% of all ...

They include uterine serous carcinomas and clear cell carcinomas. Sarcoma of the womb is different from carcinosarcoma. Carcinosarcoma is when there is a combination of sarcoma and carcinoma cells ...

In endometrial cancer, the serous subtype has less ER expression and is associated with a worse prognosis. The adrenal-restrictive HSD3B1 genotype was more commonly associated with serous-type ...

In endometrial cancer, the serous subtype has less ER expression and is associated with a worse prognosis. The adrenal-restrictive HSD3B1 genotype was more commonly associated with serous-type ...

Investigators also found genomic similarities between endometrial cancers and other tumor types. Previous TCGA research showed that a form of ovarian cancer (high-grade serous ovarian carcinoma ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

MSK specialists have made important new discoveries about endometrial cancer, including insights that may help explain why Black women are more likely to die of the disease. These researchers (shown ...

M ost uterine cancers have excellent five-year survival rates—up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Most uterine cancers are endometrioid adenocarcinomas (endometrial cancer). But other types include carcinosarcoma, serous carcinoma, clear cell carcinoma, and more. Black women have a higher risk ...

Although such patients certainly have a better prognosis than those with endometrial serous carcinoma ... Expanding TCGA-type studies to delve into novel pathways that may be associated with ...

Type I and II ECs appear to have a different ... effective systemic therapy in the treatment of this disease. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer.